Abstract

BackgroundTuberculosis (TB), an infectious disease caused by Mycobacterium tuberculosis, is a major public health concern. Chemokines and their receptors, such as RANTES, CXCR3, and CCR5, have been reported to play important roles in cell activation and migration in immune responses against TB infection.MethodsTo understand the correlations involving CCR5 gene variations, M. tuberculosis infection, and TB disease progression, a case-control study comprising 450 patients with TB and 306 healthy controls from a Chinese Han population was conducted, along with the detection of polymorphisms in the CCR5 promoter using a sequencing method.ResultsAfter adjustment for age and gender, the results of logistic analysis indicated that the frequency of rs2734648-G was significantly higher in the TB patient group (P = 0.002, OR = 1.38, 95% CI: 1.123–1.696); meanwhile, rs2734648-GG showed notable susceptibility to TB (P = 6.32E-06, OR = 2.173, 95% CI: 1.546–3.056 in a recessive model). The genotypic frequency of rs1799987 also varied between the TB and control groups (P = 0.008). In stratified analysis, rs2734648-GG significantly increased susceptibility to pulmonary TB in a recessive model (P < 0.0001, OR = 2.382, 95% CI: 1.663–3.413), and the rs2734648-G allele significantly increased susceptibility to TB recurrence in a dominant model (P = 0.0032, OR = 1.936, 95% CI: 1.221–3.068), whereas rs1799987-AA was associated with susceptibility to pulmonary TB (P = 0.0078, OR = 1.678, 95% CI: 1.141–2.495 in a recessive model) but not with extra-pulmonary TB and TB recurrence. A haplotype constructed with the major alleles of the eight SNPs in the CCR5 promoter (rs2227010-rs2856758-rs2734648-rs1799987-rs1799988-rs41469351-rs1800023-rs1800024: A-A-G-G-T-C-G-C) exhibited extraordinarily increased risk of susceptibility to TB and pulmonary TB (P = 6.33E-11, OR = 24.887, 95% CI: 6.081–101.841).ConclusionIn conclusion, CCR5 promoter polymorphisms were found to be associated with pulmonary TB and TB progression in Chinese Han people.

Highlights

  • Tuberculosis (TB) is an infectious disease caused by Mycobacterium tuberculosis (M. tuberculosis)

  • After adjustment for age and gender, the results of logistic analysis indicated that the frequency of rs2734648-G was significantly higher in the TB patient group (P = 0.002, odds ratios (OR) = 1.38, 95% confidence intervals (95% CI): 1.123–1.696); rs2734648-GG showed notable susceptibility to TB (P = 6.32E-06, OR = 2.173, 95% CI: 1.546–3.056 in a recessive model)

  • A haplotype constructed with the major alleles of the eight single nucleotide polymorphisms (SNPs) in the chemokine receptor type 5 (CCR5) promoter exhibited extraordinarily increased risk of susceptibility to TB and pulmonary TB (P = 6.33E-11, OR = 24.887, 95% CI: 6.081–101.841)

Read more

Summary

Introduction

Tuberculosis (TB) is an infectious disease caused by Mycobacterium tuberculosis (M. tuberculosis). A number of immunity-related genes have been reportedly associated with susceptibility to TB among different populations, such as human leukocyte antigen (HLA), low molecular weight polypeptide/transporter with antigen processing, natural resistance-associated macrophage protein 1 (NRAMP1), dendritic cell-specific ICAM-3-grabbing non-integrin (DCSIGN), Toll-like receptors (TLR) 1 and 2, vitamin D receptor (VDR), TNF, interleukin (IL) -1b, IL-6, IL-8, IL-10, interferon g (IFN-g), and nucleotide oligomerization binding domain 2 (NOD2) [2, 4, 6, 7] Chemokines such as chemokine (C-C motif) ligand 2 (CCL-2)/monocyte chemoattractant protein 1 (MCP-1), RANTENS (CCL5), and chemokine C-X-C motif ligand 10 (CXCL10) have been found to be relevant in M. tuberculosis infection [7]. Tuberculosis (TB), an infectious disease caused by Mycobacterium tuberculosis, is a major public health concern Chemokines and their receptors, such as RANTES, CXCR3, and CCR5, have been reported to play important roles in cell activation and migration in immune responses against TB infection

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call